SRPT

Sarepta Therapeutics, Inc. Press Releases

$12.22
*  
0.01
0.08%
Get SRPT Alerts
*Delayed - data as of Feb. 5, 2016  -  Find a broker to begin trading SRPT now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing





Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2/2/2016 5:00:00 PM - Business Wire
unchange Price Change since this news event. The Volume Ratio is 1.2.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Bragar Eagel & Squire, P.C. Is Investigating the Officers and Directors of Sarepta Therapeutics, Inc. (SRPT) on Behalf of Stockholders and Encourages Investors to Contact the Firm
1/26/2016 5:30:00 PM - Business Wire
▲1.41 % Price Change since this news event. The Volume Ratio is 0.63.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Covered Call Alerts For Sarepta Therapeutics, Anavex Life Sciences Corp, Constellation Brands, Caterpillar Inc. and Skyworks Solutions Released By InvestorsObserver
1/25/2016 9:31:00 AM - PR Newswire
▲2.17 % Price Change since this news event. The Volume Ratio is 0.29.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Claims against Sarepta Therapeutics, Inc. and Advises Investors with Losses in Excess of $100,000 to Contact the Firm
1/24/2016 9:29:00 PM - Business Wire
▼-1.13 % Price Change since this news event. The Volume Ratio is 0.27.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




INVESTOR NOTICE: Khang & Khang LLP Announces an Investigation of Claims against Sarepta Therapeutics, Inc. and Strongly Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
1/20/2016 10:09:00 PM - Business Wire
▼-6.36 % Price Change since this news event. The Volume Ratio is 0.47.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


FDA Postpones Advisory Committee Meeting to Review Eteplirsen Due to Severe Weather Storm in the Washington D.C. Area
1/20/2016 7:42:00 PM - Business Wire
▼-6.72 % Price Change since this news event. The Volume Ratio is 0.47.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




Wolf Popper LLP Announces Investigation of Fraud Claims on Behalf of Investors in Sarepta Therapeutics, Inc.
1/19/2016 9:00:00 AM - PR Newswire
▼-14.13 % Price Change since this news event. The Volume Ratio is 1.14.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


IMPORTANT SHAREHOLDER NOTICE: Khang & Khang LLP Announces an Investigation of Claims Against Sarepta Therapeutics, Inc. and Strongly Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
1/16/2016 9:01:00 PM - Business Wire
▼-13.94 % Price Change since this news event. The Volume Ratio is 1.09.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


SHAREHOLDER ALERT: Abraham, Fruchter & Twersky, LLP Announces An Investigation of Sarepta Therapeutics, Inc. (SRPT)
1/15/2016 3:46:00 PM - Business Wire
▼-13.52 % Price Change since this news event. The Volume Ratio is 4.76.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


SHAREHOLDER ALERT: The Law Offices of Vincent Wong Launch Investigation of Sarepta Therapeutics, Inc. for Possible Breaches of Fiduciary Duty
1/15/2016 1:57:00 PM - Business Wire
▼-15.55 % Price Change since this news event. The Volume Ratio is 6.69.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Sarepta Therapeutics, Inc. - SRPT
1/15/2016 11:02:00 AM - PR Newswire
▼-12.28 % Price Change since this news event. The Volume Ratio is 8.68.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
1/4/2016 4:30:00 PM - Business Wire
▼-68.09 % Price Change since this news event. The Volume Ratio is 0.8.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day






Sarepta Therapeutics Announces FDA Advisory Committee Meeting to Review Eteplirsen as a Treatment for Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping
12/18/2015 7:04:00 AM - Business Wire
▼-65.89 % Price Change since this news event. The Volume Ratio is 2.16.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day









Learn more by visiting our FAQ page